ReviewDrug discovery today2022
The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19.
Maria Sofia Basile et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
61 papers cite itlatest 60 shown
this paperpooled itcites it